Roughly 1–2% of Botox patients report mild flu-like symptoms in the 24–48 hours after their appointment — fatigue, headache, low-grade body ache, the occasional mild fever. The phenomenon has acquired a name in patient circles ('tox flu') and a small body of dismissive responses in medical ones ('that doesn't happen'). Both responses miss the mark. It does happen, sometimes, and it's worth understanding why.
What we know
The most likely mechanism is mild systemic immune response to one of the components in the formulation — most often the accessory protein complex, less often the active molecule itself. It is not the toxin spreading systemically; the dose is far too small to cause systemic effect. It's the immune system noticing the formulation and responding with general low-grade inflammation.
When it shows up
- First-time Botox patients, more often than repeat patients.
- Patients with active autoimmune flares (we screen for this).
- Patients on no sleep, severe stress, or a separate concurrent illness.
- After higher-dose treatments — full upper-third + masseter + trapezius — more often than after small touch-ups.
What we do
We screen for it. Before injecting, we ask about prior reactions, recent illness, autoimmune conditions, and how you slept the night before. For sensitive patients, we offer Xeomin (the 'naked' formulation, no accessory protein) and have seen it eliminate symptoms entirely in patients who reliably had them on Botox or Dysport. We pre-medicate with anti-inflammatories on request and recommend hydration, electrolytes, and rest after treatment. Tox flu — when it happens — resolves in 48 hours. If it doesn't, we want to know.